What is Strand Life Sciences Pvt?
Strand Life Sciences Pvt is a Bangalore-based company specializing in comprehensive genomics solutions. With over 25 years of experience, they offer a suite of services including Next-Generation Sequencing (NGS) and PCR diagnostics, alongside applications in pharma and biomarker discovery. Their platform leverages AI and real-world data to enhance the analysis and reporting of oncology-related information, providing precision medicine solutions that integrate clinical and omics data. The company serves a global clientele across the pharmaceutical, biotechnology, and academic research sectors, adhering to international standards.
How much funding has Strand Life Sciences Pvt raised?
Strand Life Sciences Pvt has raised a total of $27.6M across 3 funding rounds:
Series A
$4.6M
Series B
$10M
Private Equity
$13M
Series A (2002): $4.6M with participation from Steamboat Ventures
Series B (2013): $10M, investors not publicly disclosed
Private Equity (2018): $13M supported by HealthQuad and Quadria Capital Investment Management
Key Investors in Strand Life Sciences Pvt
HealthQuad
HealthQuad is India's leading healthcare innovation fund, focused on transforming healthcare through technology and strategic investments across the value chain, emphasizing disease prevention and quality of care.
Quadria Capital Investment Management
Quadria Capital is a prominent private equity firm specializing in strategic investments in scalable healthcare companies across Asia, aiming to drive value through deep domain expertise and operational experience.
Steamboat Ventures
Steamboat Ventures is an investment firm focused on early to growth stage companies in technology, media, and consumer sectors, dedicated to helping young companies achieve market leadership.
What's next for Strand Life Sciences Pvt?
The substantial enterprise-level funding, culminating in the recent major strategic investment, positions Strand Life Sciences Pvt for accelerated growth and expanded market reach. This capital infusion is expected to fuel further development of their AI-driven genomics platform and enhance their capabilities in precision medicine. The company's focus on integrating complex clinical and omics data, coupled with its established expertise, suggests a strategic trajectory aimed at solidifying its leadership in the rapidly evolving fields of genomics and personalized healthcare. Future initiatives will likely involve scaling operations, forging new strategic partnerships, and potentially expanding their diagnostic and discovery services.
See full Strand Life Sciences Pvt company page
